Roger Kitterman - Profile and Investment Details
Find investors who align with your industry, stage, and vision. Unlock Roger Kitterman’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors today
- Patient Care,
- Health Care,
- Hospitals,
- Wellness,
- Women Founded,
- Design,
- Healthcare Innovation,
- Telemedicine,
- Life Science,
- Rehabilitation,
- Finance,
- Bioinformatics,
- Biotechnology,
- Workforce Training,
- Communities,
- Innovation,
- Clinical Trials,
- Gene Therapy,
- Personalized Medicine,
- Telehealth,
- Web Development,
- Health Diagnostics,
- Digital Health,
- Medical,
- Information Technology,
- Therapeutics,
- Machine Learning,
- Pharmaceuticals,
- Healthcare Technology
Social media:
Past investments:
- CoStim Pharmaceuticals
- Magenta Therapeutics
- Tilos Therapeutics
- Provasculon, Inc
- ImmuneXcite
- InStore Finance
- ZielBio
- TargAnox
- Editas Medicine
- Lysosomal Therapeutics
- Adheron Therapeutics, Inc.
- Pykus Therapeutics
- Annovation BioPharma
- Abcuro
- Nocion Therapeutics
- Translate Bio
- Sebacia
- Visionscope
- ROME Therapeutics
- Lee Munder Venture Partners
- Daktari Diagnostics
- SwanBio Therapeutics
- Boston Biomedical Innovation Center
- Boston University Technology Fund
- Raze Therapeutics
- lifeIMAGE
- Keros Therapeutics
- Spero Therapeutics
- Alizé Pharma
- Health Catalyst
- Akouos
- Syntimmune
- Triplet Therapeutics
- Affinia Therapeutics
- QPID Health
Investor Profile
Roger Kitterman is a Venture Capital, Investor based in Brookline, Massachusetts, United States with a diverse investment portfolio that includes companies such as CoStim Pharmaceuticals, Magenta Therapeutics, Tilos Therapeutics, Provasculon, Inc, ImmuneXcite, InStore Finance, ZielBio, TargAnox, Editas Medicine, Lysosomal Therapeutics, Adheron Therapeutics, Inc., Pykus Therapeutics, Annovation BioPharma, Abcuro, Nocion Therapeutics, Translate Bio, Sebacia, Visionscope, ROME Therapeutics, Lee Munder Venture Partners, Daktari Diagnostics, SwanBio Therapeutics, Boston Biomedical Innovation Center, Boston University Technology Fund, Raze Therapeutics, lifeIMAGE, Keros Therapeutics, Spero Therapeutics, Alizé Pharma, Health Catalyst, Akouos, Syntimmune, Triplet Therapeutics, Affinia Therapeutics, QPID Health, . Over time, Roger Kitterman has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Roger Kitterman is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Women Founded, Design, Healthcare Innovation, Telemedicine, Life Science, Rehabilitation, Finance, Bioinformatics, Biotechnology, Workforce Training, Communities, Innovation, Clinical Trials, Gene Therapy, Personalized Medicine, Telehealth, Web Development, Health Diagnostics, Digital Health, Medical, Information Technology, Therapeutics, Machine Learning, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Roger Kitterman, as their portfolio suggests a familiarity and interest in this area.
Understanding Roger Kitterman’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today
